Atlas Trials

A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM)

Clinical trial NCT01114854 · COMPLETED

Trial details

NCT number
NCT01114854
Sponsor
Supernus Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Epilepsy
Start date
2010-06-01
Primary completion
2010-12-01
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.